"Shout out to a team at Sterne, Kessler, Goldstein & Fox led by J.C. Rozendaal, director and chair of the firm’s trial and appellate group. The Federal Circuit last week upheld an invalidity win for client Teva Pharmaceuticals concerning patents covering methods for nasally administering the overdose drug Naloxone. The Federal Circuit agreed with U.S. District Judge Brian Martinotti in New Jersey who previously found the patents obvious due to references in the prior art. The Sterne Kessler team also included directors Paul Ainsworth, Michael Joffre, Adam LaRock, William Milliken and Chandrika Vira."
To read the full article, please click the link below.